WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
1. (WO2002026998) HYDROLASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026998    International Application No.:    PCT/US2001/030310
Publication Date: 04.04.2002 International Filing Date: 28.09.2001
Chapter 2 Demand Filed:    26.04.2002    
A61K 38/00 (2006.01), C12N 9/14 (2006.01)
Applicants: INCYTE GENOMICS, INC. [US/US]; 3160 Porter Drive, Palo Alto, CA 94304 (US) (For All Designated States Except US).
YUE, Henry [US/US]; (US) (For US Only).
BAUGHN, Mariah, R. [US/US]; (US) (For US Only).
WARREN, Bridget, A. [US/US]; (US) (For US Only).
TRIBOULEY, Catherine, M. [US/US]; (US) (For US Only).
TANG, Y., Tom [US/US]; (US) (For US Only).
KHAN, Farrah, A. [IN/US]; (US) (For US Only).
YAO, Monique, G. [US/US]; (US) (For US Only).
LAL, Preeti [IN/US]; (US) (For US Only).
THORNTON, Michael [US/US]; (US) (For US Only)
Inventors: YUE, Henry; (US).
BAUGHN, Mariah, R.; (US).
WARREN, Bridget, A.; (US).
TRIBOULEY, Catherine, M.; (US).
TANG, Y., Tom; (US).
KHAN, Farrah, A.; (US).
YAO, Monique, G.; (US).
LAL, Preeti; (US).
THORNTON, Michael; (US)
Agent: HAMLET-COX, Diana; Incyte Genomics, Inc., 3160 Porter Drive, Palo Alto, CA 94304 (US)
Priority Data:
60/237,093 29.09.2000 US
60/238,370 06.10.2000 US
60/241,284 17.10.2000 US
Abstract: front page image
(EN)The invention provides human hydrolases (HYDR) and polynucleotides which identify and encode HYDR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HYDR.
(FR)L'invention concerne des hydrolases humaines (HYDR) et des polynucléotides qui identifient et codent des HYDR. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Par ailleurs, l'invention concerne des procédés de diagnostic, de traitement ou de prévention de troubles associés à l'expression anormale des HYDR.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)